×
模态框(Modal)标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框(Modal)标题
在这里添加一些文本
Close
×
中文
|
English
Toggle navigation
Home
About Journal
Editorial Board
News
cooperation
Cooperation Content
cooperative partner
Subscription
Current Issue
Policy ethics
Download
Contact Us
A meta-analysis of the efficacy and safety of HDAC inhibitors combined with exemestane in the treatment of HR+/HER2- advanced Metastatic breast cancer
LI Shuo, YANG Zhi-xuan, GONG Wen-lin, QIE Hong-xin, WANG Pei-yuan, GAO Xiao-nan, GAO Jing-lin, WANG Ming-xia
Chinese Journal of New Drugs . 2026, (
18
): 1999 -2008 . DOI: 10.20251/j.cnki.1003-3734.2026.18.012